These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 4253580

  • 1. [Resistance to colchicine in a glycogen-containing subline of the Ehrlich-Lettré-ascites-tumour].
    Granzow C, Ehe-Galster U.
    Z Krebsforsch; 1970; 74(4):329-37. PubMed ID: 4253580
    [No Abstract] [Full Text] [Related]

  • 2. Sublines of the Ehrlich-Lettré mouse ascites tumour. A new tool for experimental cell research.
    Lettré R, Paweletz N, Werner D, Granzow C.
    Naturwissenschaften; 1972 Feb; 59(2):59-63. PubMed ID: 5015750
    [No Abstract] [Full Text] [Related]

  • 3. [The mitosis rate in Jensen sarcoma, in a DANA lung carcinoma and in Ehrlich ascites tumor in iron deficiency and iron overloading].
    Kranz D, Schmidt UJ, Kalbe I, Brüschke G, Pasternak G.
    Acta Biol Med Ger; 1969 Feb; 22(3):653-6. PubMed ID: 4903492
    [No Abstract] [Full Text] [Related]

  • 4. Studies of the liver glycogen of mice during the growth of a glycogen-free and a glycogen-containing subline of the Ehrlich-Lettré ascites tumour.
    Granzow C, Beheim P.
    Eur J Cancer (1965); 1972 Apr; 8(2):225-30. PubMed ID: 5073294
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Persistence of colchicine resistance in Ehrlich-Lettré ascites tumors and cell strains.
    Granzow C.
    J Cancer Res Clin Oncol; 1981 Apr; 102(1):57-69. PubMed ID: 7334053
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Cell division in Ehrlich ascites tumor and survival of mice after administration of chalone].
    Savchenko TV, Zakharov VB, Mamontov SG, Romanov IuA.
    Vestn Akad Med Nauk SSSR; 1980 Apr; (11):54-9. PubMed ID: 6451996
    [No Abstract] [Full Text] [Related]

  • 12. [Mitosis activity of Ehrlich ascites carcinoma of the albine meuse after intraperitoneal hyaluronidase administration].
    Seipelt H, Kohlheb O.
    Arzneimittelforschung; 1967 Apr; 17(4):513-4. PubMed ID: 5632454
    [No Abstract] [Full Text] [Related]

  • 13. On the G2 arrest of Ehrlich ascites tumour cells during the tumour regression in rats.
    Janik P.
    Neoplasma; 1974 Apr; 21(4):415-9. PubMed ID: 4431540
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE, Maguire JA, Kitchlew TZ, Swyers WA, Volk PZ, Croft JR, Quigley MJ, Fries JR, Oser NA, Anderson LJ.
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract] [Full Text] [Related]

  • 15. [Cell division reaction in mouse Ehrlich ascites tumor in response to adrenaline].
    Romanov IuA, Biks KA.
    Biull Eksp Biol Med; 1981 Jul; 91(1):69-71. PubMed ID: 7214012
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Contribution to the study of the Ehrlich-ascites tumor cells. A cytological and cytochemical analysis of the effects of sarcolysine.
    Bassleer R, Desaive C.
    Eur J Cancer (1965); 1971 Oct; 7(5):441-50. PubMed ID: 5159874
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.